FDA Orange Book · active-ingredient family
Mycophenolate mofetil
Mycophenolate mofetil: 4 brands, 42 generics; first approved May 03, 1995; generic available.
Generic availableHas discontinued products
Generic status & protection
Generic available: 42 ANDA applications approved.
Earliest patent expiry
Brands (NDA)
4
Generics (ANDA)
42
Listed patents
5
Next patent expiry
Aug 16, 2039
in 13 yr
Brand (NDA) products
Originator applications
- AZURITYNDA 2164822024
Approved strengths under this FDA application. Strength Dosage form Route Status TE 200MG/ML SUSPENSION ORAL Rx — - ROCHE PALONDA 0507591998
Approved strengths under this FDA application. Strength Dosage form Route Status TE 200MG/ML FOR SUSPENSION ORAL Rx AB - ROCHE PALONDA 0507231997
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Rx AB - ROCHE PALONDA 0507221995
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG CAPSULE ORAL Rx AB
Generic (ANDA) products (42)
Abbreviated applications
- MYCOPHENOLATE MOFETILCONCORD BIOTECH LTDANDA 2185662026
Approved strengths under this FDA application. Strength Dosage form Route Status TE 200MG/ML FOR SUSPENSION ORAL Rx AB - MYCOPHENOLATE MOFETILWUXIANDA 2140792024
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG CAPSULE ORAL Rx AB - MYCOPHENOLATE MOFETILHETERO LABS LTD VANDA 2070222024
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG CAPSULE ORAL Rx AB - MYCOPHENOLATE MOFETILHETERO LABS LTD VANDA 2081192024
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Rx AB - MYCOPHENOLATE MOFETILAUROBINDO PHARMA LTDANDA 2182272024
Approved strengths under this FDA application. Strength Dosage form Route Status TE 200MG/ML FOR SUSPENSION ORAL Rx AB - MYCOPHENOLATE MOFETILAUROBINDO PHARMAANDA 2179372024
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Rx AB - MYCOPHENOLATE MOFETILAUROBINDO PHARMA LTDANDA 2178282024
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG CAPSULE ORAL Rx AB - MYCOPHENOLATE MOFETILRISINGANDA 2139552023
Approved strengths under this FDA application. Strength Dosage form Route Status TE 200MG/ML FOR SUSPENSION ORAL Rx AB - MYCOPHENOLATE MOFETILSTRIDES PHARMA INTLANDA 2126342023
Approved strengths under this FDA application. Strength Dosage form Route Status TE 200MG/ML FOR SUSPENSION ORAL Rx AB - MYCOPHENOLATE MOFETILTEVA PHARMS USAANDA 2112722022
Approved strengths under this FDA application. Strength Dosage form Route Status TE 200MG/ML FOR SUSPENSION ORAL Discontinued — - MYCOPHENOLATE MOFETILAMNEALANDA 2148712021
Approved strengths under this FDA application. Strength Dosage form Route Status TE 200MG/ML FOR SUSPENSION ORAL Rx AB - MYCOPHENOLATE MOFETILQUAGENANDA 2145252021
Approved strengths under this FDA application. Strength Dosage form Route Status TE 200MG/ML FOR SUSPENSION ORAL Rx AB - MYCOPHENOLATE MOFETILCONCORD BIOTECH LTDANDA 2120872020
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Rx AB - MYCOPHENOLATE MOFETILVISTAPHARM LLCANDA 2103702019
Approved strengths under this FDA application. Strength Dosage form Route Status TE 200MG/ML FOR SUSPENSION ORAL Rx AB - MYCOPHENOLATE MOFETILCONCORD BIOTECH LTDANDA 2101812019
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG CAPSULE ORAL Rx AB - MYCOPHENOLATE MOFETILZHEJIANG HISUN PHARMANDA 2040762017
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Rx AB - MYCOPHENOLATE MOFETILZHEJIANG HISUN PHARMANDA 2040772017
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG CAPSULE ORAL Rx AB - MYCOPHENOLATE MOFETILJUBILANT CADISTAANDA 0907622014
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG CAPSULE ORAL Discontinued — - MYCOPHENOLATE MOFETILJUBILANT CADISTAANDA 0906612014
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Discontinued — - MYCOPHENOLATE MOFETILALKEM LABS LTDANDA 2030052014
Approved strengths under this FDA application. Strength Dosage form Route Status TE 200MG/ML FOR SUSPENSION ORAL Rx AB - MYCOPHENOLATE MOFETILALKEM LABS LTDANDA 2001972013
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG CAPSULE ORAL Rx AB - MYCOPHENOLATE MOFETILALKEM LABS LTDANDA 0912492011
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Rx AB - MYCOPHENOLATE MOFETILDR REDDYS LABS LTDANDA 0913152011
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG CAPSULE ORAL Discontinued — - MYCOPHENOLATE MOFETILDR REDDYS LABS LTDANDA 0904642010
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Discontinued — - MYCOPHENOLATE MOFETILAMNEALANDA 0906062010
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Discontinued — - MYCOPHENOLATE MOFETILSTRIDES PHARMAANDA 0900552010
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG CAPSULE ORAL Rx AB - MYCOPHENOLATE MOFETILSTRIDES PHARMAANDA 0904562010
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Rx AB - MYCOPHENOLATE MOFETILSTRIDES PHARMA INTLANDA 0901112009
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG CAPSULE ORAL Discontinued — - MYCOPHENOLATE MOFETILTEVA PHARMSANDA 0654912009
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG CAPSULE ORAL Rx AB - MYCOPHENOLATE MOFETILACCORD HLTHCAREANDA 0902532009
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG CAPSULE ORAL Rx AB - MYCOPHENOLATE MOFETILMYLANANDA 0655202009
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG CAPSULE ORAL Discontinued — - MYCOPHENOLATE MOFETILZYDUS PHARMS USA INCANDA 0654332009
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG CAPSULE ORAL Discontinued — - MYCOPHENOLATE MOFETILACCORD HLTHCAREANDA 0654162009
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Rx AB - MYCOPHENOLATE MOFETILMYLANANDA 0655212009
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Discontinued — - MYCOPHENOLATE MOFETILTEVA PHARMSANDA 0654572009
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Discontinued — - MYCOPHENOLATE MOFETILZYDUS PHARMS USA INCANDA 0654772009
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Discontinued — - MYCOPHENOLATE MOFETILAPOTEX CORPANDA 0904192009
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG CAPSULE ORAL Discontinued — - MYCOPHENOLATE MOFETILAPOTEXANDA 0904992009
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Discontinued — - MYCOPHENOLATE MOFETILSANDOZANDA 0653792008
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG CAPSULE ORAL Rx AB - MYCOPHENOLATE MOFETILSANDOZANDA 0654512008
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Rx AB - MYCOPHENOLATE MOFETILHIKMAANDA 0654102008
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG CAPSULE ORAL Discontinued — - MYCOPHENOLATE MOFETILHIKMAANDA 0654132008
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Discontinued —
Patent & exclusivity timeline
Protection horizon
Patent expiryExclusivity endToday
Listed patents
Orange Book patent file
| Patent | Expires | In | Type |
|---|---|---|---|
| 12194143 | in 13 yr | ProductU-1752 | |
| 12097285 | in 13 yr | ProductU-1752 | |
| 12226526 | in 13 yr | ProductU-1752 | |
| 11931455 | in 13 yr | ProductU-1752 | |
| 12097284 | in 13 yr | Product |
Approval history
FDA approval span
First approval
31 yr 11 mo ago
Most recent approval
5 mo ago
Approvals span 1995–2026 across 46 FDA applications.
Brand (NDA) 49%
Generic (ANDA) 4291%
Mycophenolate mofetil: frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
Go beyond the database.
Try Assyro Intelligence for your regulatory research. Ready to discuss your team’s workflow? Book a demo.